Stopping, and what happens next

Stopping is the part of this treatment discussed least and planned for least, which is odd given that almost everyone stops eventually — because they reached a goal, because supply failed, because of cost, or because life intervened.

What follows is not a warning against stopping. It is a description of what the evidence shows, so that if you stop it is a decision with a plan attached rather than an event that happens to you.

What the first month feels like

The pharmacology sets the pace. These drugs clear over about five half-lives — roughly five weeks for the weekly products — and the appetite effect fades along that curve rather than ending with the last injection.

Week one after stopping usually feels much like the week before. Week two brings small changes people often attribute to something else. By week four the difference is unmistakable: portions that were satisfying are not, and the background hum of thinking about food — quiet for months — comes back.

The gradualness is the trap. There is no moment that announces itself, so there is no obvious point at which to start doing something differently. By the time the change is clear, several weeks of drift have already happened. The underlying arithmetic is here.

What the trials show

The evidence on this is consistent and uncomfortable. Across withdrawal studies of these medicines, participants who stopped regained a substantial proportion of the weight they had lost within a year, and cardiometabolic improvements moved back toward baseline alongside it.

This finding is often reported as though it were a failure of the drug. It is better understood as a description of what the drug does: it changes appetite signalling while it is present. When it is not present, the signalling returns to what it was. In that respect it behaves like most medicines for chronic conditions — blood pressure rises again when antihypertensives stop, and nobody describes that as the medicine having failed.

The clinical framing that follows from this is that obesity is being treated as a chronic condition rather than cured. Whether that framing is right for you is a conversation with your prescriber, not something a website settles.

What actually seems to help

Four things have the best claim, and none of them is a supplement.

Muscle preserved on the way down

This is the largest lever and it is decided months before you stop. Weight lost quickly, on low protein and without resistance training, includes a meaningful share of lean tissue — and lean tissue is metabolically active. Lose it and you return to your starting weight with a lower resting energy expenditure than you began with, which makes regain easier and further loss harder. This is the argument for protein and resistance training in one sentence.

A slower taper rather than a stop

Stepping down through the ladder rather than stopping from a maintenance dose gives you a longer window in which appetite is partially suppressed and habits are being tested. Whether this changes long-term outcomes is not settled, but it converts an abrupt transition into a gradual one — and it is a prescribing decision, not one to make alone.

Habits established while it was easy

The months on treatment are the easiest months you will ever have for building eating patterns, because the biological argument against them is quiet. Habits built then are the ones that survive; resolutions made in week four after stopping are made in the hardest possible conditions.

Knowing the number that triggers action

Decide in advance what regain would prompt a conversation — a specific figure, agreed before you stop. Drift is easier to interrupt at three kilograms than at fifteen, and a number decided in advance removes the negotiation with yourself that otherwise happens at every stage.

Restarting

Restarting is common and is not a failure. Two practical points matter.

First, expect to re-escalate rather than resume. After a break of more than a few weeks, gastrointestinal tolerance has faded even though your memory of it has not. Resuming at your previous dose frequently reproduces a first escalation at full strength.

Second, restarting is a prescribing decision. Where the medicine treats diabetes, stopping and restarting affects glucose control directly, and that is not something to manage from a supply of leftover pens.

When stopping is not your choice

Supply interruptions and cost changes end treatments regularly, and they do it without notice. If your treatment depends on a product that has been intermittently available, it is worth asking your prescriber in advance what the alternative would be — before you need it. We cover the practical side here.

The honest summary

Stopping generally means appetite returns, and for most people weight follows. That is a description of a mechanism rather than a moral verdict on anyone.

What you can influence is how much of what you lost was fat rather than muscle, how gradual the transition is, and whether you notice drift early enough to act on it. None of those is guaranteed to work. All of them are better than being surprised.

Related

• Protein, and the muscle you don't want to lose — Rapid weight loss takes lean tissue with it unless you make it not. This is the least discussed and most consequential part of GLP-1 treatment.
• When the scale stops moving — Most stalls are not plateaus. Distinguishing the two comes down to where you are on the dose ladder and how long the flat stretch has lasted.
• Exercise while you are losing weight — Not for the calories. Resistance training is what tells your body to keep the muscle it would otherwise break down.
• Hair shedding on a GLP-1 — Common, alarming, and usually not the drug. What telogen effluvium is, why rapid weight loss triggers it, and what actually helps.

Which medicine you are on

Everything above applies across the class, because it comes from a shared mechanism. The numbers that differ — dose ladders, missed-dose windows, in-use storage periods, half-lives — differ by product, sometimes substantially. Each medicine has its own reference here:

Ozempic · Wegovy · Mounjaro · Zepbound · Rybelsus · Saxenda · Victoza · Trulicity · all medicines